Dane Huang

570 total citations
29 papers, 477 citations indexed

About

Dane Huang is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Dane Huang has authored 29 papers receiving a total of 477 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 8 papers in Oncology and 5 papers in Surgery. Recurrent topics in Dane Huang's work include Bone Metabolism and Diseases (8 papers), Bone health and treatments (5 papers) and Computational Drug Discovery Methods (5 papers). Dane Huang is often cited by papers focused on Bone Metabolism and Diseases (8 papers), Bone health and treatments (5 papers) and Computational Drug Discovery Methods (5 papers). Dane Huang collaborates with scholars based in China, United States and Australia. Dane Huang's co-authors include Jun Xu, Qiong Gu, Dake Cai, Haining Gan, Nan Yao, Ge Hu, Chao Zhao, Zhihong Liu, Yuxing Chen and Hui Cui and has published in prestigious journals such as Nature Communications, PLoS ONE and Biochemical and Biophysical Research Communications.

In The Last Decade

Dane Huang

27 papers receiving 469 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dane Huang China 15 287 87 66 62 55 29 477
Mohammad Abdullah Aljasir Saudi Arabia 14 341 1.2× 83 1.0× 95 1.4× 96 1.5× 47 0.9× 31 696
Gaurav Parashar India 14 379 1.3× 96 1.1× 37 0.6× 23 0.4× 49 0.9× 26 597
Shyam N. Sundar United States 11 327 1.1× 54 0.6× 44 0.7× 39 0.6× 92 1.7× 11 575
Jae Hoon Kim South Korea 18 411 1.4× 85 1.0× 57 0.9× 33 0.5× 116 2.1× 34 778
Sami Hamdoun Germany 10 207 0.7× 31 0.4× 57 0.9× 63 1.0× 57 1.0× 17 413
Judit Mihaly‐Bison Austria 10 308 1.1× 74 0.9× 71 1.1× 32 0.5× 51 0.9× 13 622
Hua‐Li Zuo China 14 261 0.9× 70 0.8× 106 1.6× 55 0.9× 33 0.6× 40 582
Rafiq A. Rather India 9 217 0.8× 41 0.5× 100 1.5× 23 0.4× 70 1.3× 11 495
Jen‐Jie Lin Taiwan 13 263 0.9× 67 0.8× 37 0.6× 22 0.4× 34 0.6× 20 555

Countries citing papers authored by Dane Huang

Since Specialization
Citations

This map shows the geographic impact of Dane Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dane Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dane Huang more than expected).

Fields of papers citing papers by Dane Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dane Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dane Huang. The network helps show where Dane Huang may publish in the future.

Co-authorship network of co-authors of Dane Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Dane Huang. A scholar is included among the top collaborators of Dane Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dane Huang. Dane Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gao, Jun, et al.. (2025). GNPS-guided isolation of anti-osteoporosis neoclerodane diterpenoids from Ajuga bracteosa. Bioorganic Chemistry. 164. 108841–108841.
2.
Xu, Hua‐Zhen, Xiuli Lu, Mei Li, et al.. (2024). Jiangu formula: A novel osteoclast-osteoblast coupling agent for effective osteoporosis treatment. Phytomedicine. 128. 155501–155501. 5 indexed citations
4.
Liu, Wengang, et al.. (2022). Long noncoding RNA PVT1 promotes chondrocyte extracellular matrix degradation by acting as a sponge for miR-140 in IL-1β-stimulated chondrocytes. Journal of Orthopaedic Surgery and Research. 17(1). 218–218. 11 indexed citations
5.
Huang, Dane, Chao Zhao, Yuting Zhang, et al.. (2022). Identification of a binding site on soluble RANKL that can be targeted to inhibit soluble RANK-RANKL interactions and treat osteoporosis. Nature Communications. 13(1). 5338–5338. 39 indexed citations
6.
Lin, Guangyao, Haining Gan, Nan Yao, et al.. (2022). Isochlorogenic Acid C Alleviates High-Fat Diet-Induced Hyperlipemia by Promoting Cholesterol Reverse Transport. Frontiers in Pharmacology. 13. 881078–881078. 14 indexed citations
7.
Chen, Hao, Hua Pei, Dane Huang, et al.. (2022). Discovery of Spiro[pyrrolidine-3,3′-oxindole] LXRβ Agonists for the Treatment of Osteoporosis. Journal of Medicinal Chemistry. 66(1). 752–765. 8 indexed citations
8.
Hu, Zixuan, Haili Gao, Xuejun Huang, et al.. (2021). Cordyceps militaris extract induces apoptosis and pyroptosis via caspase‐3/PARP/GSDME pathways in A549 cell line. Food Science & Nutrition. 10(1). 21–38. 24 indexed citations
9.
Liu, Zhihong, Dane Huang, Shuangjia Zheng, et al.. (2020). Deep learning enables discovery of highly potent anti-osteoporosis natural products. European Journal of Medicinal Chemistry. 210. 112982–112982. 29 indexed citations
10.
11.
Huang, Dane, et al.. (2019). Diterpenoids from the aerial parts of Flueggea acicularis and their activity against RANKL-induced osteoclastogenesis. Bioorganic Chemistry. 94. 103453–103453. 13 indexed citations
12.
Cai, Dake, et al.. (2018). Mechanism of YLTZ on glycolipid metabolism based on UPLC/TOF/MS metabolomics. Journal of Chromatography B. 1097-1098. 128–141. 14 indexed citations
13.
Cui, Hui, Dane Huang, Zhengrui Zhang, et al.. (2017). Chroman-4-one and pyrano[4,3-b]chromenone derivatives from the mangrove endophytic fungus Diaporthe phaseolorum SKS019. RSC Advances. 7(33). 20128–20134. 19 indexed citations
14.
Wang, Shaoxiang, Xiao Wang, Yuting Liu, et al.. (2014). SNX-25a, a novel Hsp90 inhibitor, inhibited human cancer growth more potently than 17-AAG. Biochemical and Biophysical Research Communications. 450(1). 73–80. 10 indexed citations
15.
Sun, Dongmei, et al.. (2014). Piperine potentiates the hypocholesterolemic effect of curcumin in rats fed on a high fat diet. Experimental and Therapeutic Medicine. 8(1). 260–266. 34 indexed citations
16.
Wang, Xiao, Shaoxiang Wang, Yuting Liu, et al.. (2014). Comparative effects of SNX-7081 and SNX-2112 on cell cycle, apoptosis and Hsp90 client proteins in human cancer cells. Oncology Reports. 33(1). 230–238. 10 indexed citations
17.
Chen, Jia, Dane Huang, Wei Chen, et al.. (2014). Linker-Extended Native Cyanovirin-N Facilitates PEGylation and Potently Inhibits HIV-1 by Targeting the Glycan Ligand. PLoS ONE. 9(1). e86455–e86455. 14 indexed citations
18.
Zeng, Fanli, Yangfei Xiang, Xiao Wang, et al.. (2013). Anti-Hepatitis B Virus Effects of Dehydrocheilanthifoline fromCorydalis saxicola. The American Journal of Chinese Medicine. 41(1). 119–130. 26 indexed citations
19.
Huang, Dane, Qiong Gu, Ge Hu, et al.. (2012). On the Value of Homology Models for Virtual Screening: Discovering hCXCR3 Antagonists by Pharmacophore-Based and Structure-Based Approaches. Journal of Chemical Information and Modeling. 52(5). 1356–1366. 25 indexed citations
20.
Huang, Dane. (1993). [The usefulness of serum antibody to Epstein-Barr virus-specific DNAase (EDAb) in early detection of nasopharyngeal carcinoma].. PubMed. 15(4). 289–91. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026